{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:24:14Z","timestamp":1789687454988,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008109","name":"Wuxi Municipal Bureau on Science and Technology","doi-asserted-by":"publisher","award":["Y20232009"],"award-info":[{"award-number":["Y20232009"]}],"id":[{"id":"10.13039\/501100008109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007289","name":"Nanjing Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017837","name":"Wuxi Science and Technology Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.arcmed.2025.103283","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T15:16:39Z","timestamp":1755616599000},"page":"103283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Monocarboxylate Transporter 4 Inhibition Reduces Synovial Hyperproliferation and Metabolic Reprogramming Under Hypoxia in Rheumatoid Arthritis"],"prefix":"10.1016","volume":"57","author":[{"given":"Meican","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5296-2039","authenticated-orcid":false,"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7943-1572","authenticated-orcid":false,"given":"Fenghong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2025.103283_bib0001","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","article-title":"Rheumatoid arthritis","volume":"402","author":"Di Matteo","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2025.103283_bib0002","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12929-016-0281-0","article-title":"Hypoxia and its implications in rheumatoid arthritis","volume":"23","author":"Quinonez-Flores","year":"2016","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.arcmed.2025.103283_bib0003","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41584-022-00771-x","article-title":"Cellular metabolic adaptations in rheumatoid arthritis and their therapeutic implications","volume":"18","author":"Fearon","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.arcmed.2025.103283_bib0004","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrrheum.2016.20","article-title":"Rheumatoid arthritis: could glucose metabolism be a sweet target for RA therapy?","volume":"12","author":"Onuora","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.arcmed.2025.103283_bib0005","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1136\/annrheumdis-2021-222021","article-title":"Synovial fibroblasts as potential drug targets in rheumatoid arthritis, where do we stand and where shall we go?","volume":"81","author":"Nemeth","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arcmed.2025.103283_bib0006","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/imr.12838","article-title":"Immunometabolism in the development of rheumatoid arthritis","volume":"294","author":"Weyand","year":"2020","journal-title":"Immunol Rev"},{"key":"10.1016\/j.arcmed.2025.103283_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2023.01.007","article-title":"Targeting monocarboxylate transporters (MCTs) in cancer: how close are we to the clinics?","volume":"90","author":"Singh","year":"2023","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.arcmed.2025.103283_bib0008","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.apsb.2019.12.006","article-title":"Solute carrier transporters: the metabolic gatekeepers of immune cells","volume":"10","author":"Song","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.arcmed.2025.103283_bib0009","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12933-024-02178-2","article-title":"MCT4-dependent lactate transport: a novel mechanism for cardiac energy metabolism injury and inflammation in type 2 diabetes mellitus","volume":"23","author":"Ma","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.arcmed.2025.103283_bib0010","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1002\/art.39270","article-title":"Monocarboxylate transporter 4, associated with the acidification of synovial fluid, is a novel therapeutic target for inflammatory arthritis","volume":"67","author":"Fujii","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.arcmed.2025.103283_bib0011","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","article-title":"Mitochondrial TCA cycle metabolites control physiology and disease","volume":"11","author":"Martinez-Reyes","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.arcmed.2025.103283_bib0012","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s13238-017-0451-1","article-title":"The emerging role and targetability of the TCA cycle in cancer metabolism","volume":"9","author":"Anderson","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.arcmed.2025.103283_bib0013","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.molcel.2010.08.031","article-title":"Central carbon metabolism as a minimal biochemical walk between precursors for biomass and energy","volume":"39","author":"Noor","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.arcmed.2025.103283_bib0014","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.biotechadv.2017.09.006","article-title":"Learning from quantitative data to understand central carbon metabolism","volume":"35","author":"Matsuda","year":"2017","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.arcmed.2025.103283_bib0015","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cmet.2020.12.003","article-title":"The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure","volume":"33","author":"Cluntun","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.arcmed.2025.103283_bib0016","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.molcel.2020.12.012","article-title":"Increased demand for NAD(+) relative to ATP drives aerobic glycolysis","volume":"81","author":"Luengo","year":"2021","journal-title":"Mol Cell"},{"key":"10.1016\/j.arcmed.2025.103283_bib0017","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1182\/blood.2021011563","article-title":"Proton export alkalinizes intracellular ph and reprograms carbon metabolism to drive normal and malignant cell growth","volume":"139","author":"Man","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2025.103283_bib0018","doi-asserted-by":"crossref","first-page":"eabi8602","DOI":"10.1126\/sciadv.abi8602","article-title":"Lactate supports a metabolic-epigenetic link in macrophage polarization","volume":"7","author":"Noe","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.arcmed.2025.103283_bib0019","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.tem.2024.01.011","article-title":"Lysine lactylation in the regulation of tumor biology","volume":"35","author":"Yang","year":"2024","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2025.103283_bib0020","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.ccell.2024.09.006","article-title":"Lactylation in cancer: current understanding and challenges","volume":"42","author":"Li","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.arcmed.2025.103283_bib0021","article-title":"Lactate and lactylation in gastrointestinal cancer: current progress and perspectives (review)","volume":"53","author":"He","year":"2025","journal-title":"Oncol Rep"},{"key":"10.1016\/j.arcmed.2025.103283_bib0022","article-title":"Mitochondrial pyruvate transport regulates presynaptic metabolism and neurotransmission","author":"Tiwari","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.arcmed.2025.103283_bib0023","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41556-018-0118-z","article-title":"Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours","volume":"20","author":"Garcia-Bermudez","year":"2018","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.arcmed.2025.103283_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102974","article-title":"Altered lipid metabolism in synovial fibroblasts of individuals at risk of developing rheumatoid arthritis","volume":"134","author":"de Jong","year":"2023","journal-title":"J Autoimmun"},{"key":"10.1016\/j.arcmed.2025.103283_bib0025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrrheum.2016.69","article-title":"Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis","volume":"12","author":"Fearon","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.arcmed.2025.103283_bib0026","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12935-019-0904-0","article-title":"Interfering cellular lactate homeostasis overcomes taxol resistance of breast cancer cells through the microRNA-124-mediated lactate transporter (MCT1) inhibition","volume":"19","author":"Hou","year":"2019","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.arcmed.2025.103283_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173238","article-title":"Role of JAK-STAT signaling in the pathogenic behavior of fibroblast-like synoviocytes in rheumatoid arthritis: effect of the novel JAK inhibitor peficitinib","volume":"882","author":"Emori","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.arcmed.2025.103283_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.984408","article-title":"Solute carrier nutrient transporters in rheumatoid arthritis fibroblast-like synoviocytes","volume":"13","author":"Torres","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.arcmed.2025.103283_bib0029","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/13510002.2022.2046423","article-title":"Role of mitochondrial reactive oxygen species in homeostasis regulation","volume":"27","author":"Zhang","year":"2022","journal-title":"Redox Rep"},{"key":"10.1016\/j.arcmed.2025.103283_bib0030","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.molcel.2020.12.026","article-title":"R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO\/m(6)a\/PFKP\/LDHB axis","volume":"81","author":"Qing","year":"2021","journal-title":"Mol Cell"},{"key":"10.1016\/j.arcmed.2025.103283_bib0031","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41569-018-0059-z","article-title":"Mitochondrial quality control mechanisms as molecular targets in cardiac ageing","volume":"15","author":"Picca","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.arcmed.2025.103283_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.725641","article-title":"Spontaneously resolving joint inflammation is characterised by metabolic agility of fibroblast-like synoviocytes","volume":"12","author":"Falconer","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.arcmed.2025.103283_bib0033","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/hep.32348","article-title":"Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing t cell infiltration and immune attack","volume":"77","author":"Fang","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2025.103283_bib0034","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ymben.2012.11.010","article-title":"Parallel labeling experiments and metabolic flux analysis: past, present and future methodologies","volume":"16","author":"Crown","year":"2013","journal-title":"Metab Eng"},{"key":"10.1016\/j.arcmed.2025.103283_bib0035","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ymben.2023.04.008","article-title":"A contribution of metabolic engineering to addressing medical problems: metabolic flux analysis","volume":"77","author":"Lee","year":"2023","journal-title":"Metab Eng"},{"key":"10.1016\/j.arcmed.2025.103283_bib0036","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13075-024-03343-4","article-title":"Targeting pathogenic fibroblast-like synoviocyte subsets in rheumatoid arthritis","volume":"26","author":"Qian","year":"2024","journal-title":"Arthritis Res Ther"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440925001031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440925001031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T14:11:02Z","timestamp":1771855862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440925001031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0188440925001031"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2025.103283","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monocarboxylate Transporter 4 Inhibition Reduces Synovial Hyperproliferation and Metabolic Reprogramming Under Hypoxia in Rheumatoid Arthritis","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2025.103283","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103283"}}